Chronic Pain and Transcranial Direct Current Stimulation in Clinical Settings
NCT ID: NCT04726423
Last Updated: 2023-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2021-01-04
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Direct Current Stimulation for Chronic Pain Relief
NCT01220323
Relieving Chronic Pain in Older Adults With Transcranial Direct Current Stimulation
NCT05617027
Transcranial Direct Current Stimulation in Clinical Setting to Reduce Pain in Older Workers
NCT05370833
Transcranial Direct Current Stimulation for Chronic Low Back Pain
NCT02768129
Exploration of Parameters of Transcranial Direct Current Stimulation (tDCS) in Chronic Pain
NCT01402960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Concerning tDCS treatment, patients were encouraged to receive 1 tDCS session per day for 5 consecutive days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial direct current stimulation
5 daily sessions of tDCS (2mA, 20 min) were recommended to all patients. Physical exercises were also done at the physiotherapy clinic. Physical exercises program was recommended to be continued at home after the week of physiotherapy visits.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guillaume Léonard
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Leonard, PhD
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Physio-Atlas
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Antoine Laramé, M.Sc.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-3273-PA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.